Amwill Health Care Ltd Approves Comprehensive Investment Limits for Treasury Management
Amwill Health Care Limited has approved specific investment limits derived from its internal accruals as part of a new hybrid treasury strategy designed to optimize surplus cash. The company aims to maintain prudent balance sheet management by allocating defined portions of capital into an active multi-asset framework, balancing absolute safety with the opportunity to capture higher risk-adjusted returns on excess capital.The approved investments will be across five distinct categories, each assigned a maximum aggregate limit:
| Investment Category | Maximum Aggregate Limit (INR) |
|---|---|
| Government Securities and Debt Instruments (G-Secs, NCDs, etc.) | 10,00,00,000 (Rupees Ten Crore Only) |
| Listed Equity and IPO Subscriptions | 2,00,00,000 (Rupees Two Crore Only) |
| Private Credit Funds and Alternative Investment Funds (AIFs) | 15,00,00,000 (Rupees Fifteen Crore Only) |
| Invoice Discounting Platforms and Other Opportunities | 3,00,00,000 (Indian Rupees Three Crore Only) |
| Mutual Fund Investments via SIPs (Equity and Debt-Oriented Schemes) | 3,00,00,000 (Indian Rupees Three Crore Only) |
The strategic approach ensures that while a primary base of liquid reserves remains anchored in traditional Bank Fixed Deposits for operational liquidity and absolute safety, the company is diversifying its surplus capital.
The Investments approved by the Investment Committee do not involve any related party transactions.
Stock Price Movement
Amwill Health Care Ltd settled on Friday at ₹41.50, recording a loss of 1.26% after the market close. The shares experienced movement during the trading session, ranging from an intraday low of ₹41.50 to a high of ₹42.03.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.